U.S. orthopedic soft tissue repair hit $2.3B in 2024, projected near $3.4B by 2031, driven by outpatient arthroscopy ...
ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its ...
FRANKLIN LAKES, N.J., July 27, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tepha, Inc., a leading ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of ...
Dec 11 (Reuters) - CryoLife Inc. said its device for reinforcing weakened soft tissues has been cleared by the U.S. Food and Drug Administration, sending its shares up over 9 percent. The approval is ...
U.S. orthopedic soft tissue repair hit $2.3B in 2024, projected near $3.4B by 2031, driven by outpatient arthroscopy and sports injuries. VANCOUVER, BRITISH COLUMBIA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results